石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01093 石药集团

未开盘 10-13 16:08:28

9.065

+0.040

+0.44%

最高9.080	最低8.810	成交量4,492万
今开9.000	昨收9.025	日振幅2.99%
总市值1,044亿	流通市值1,044亿	总股本115.22亿
成交额4.02亿	换手率0.39%	流通股本115.22亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01093","market":"HK","secType":"STK","nameCN":"石药集团","latestPrice":9.065,"timestamp":1791878908004,"preClose":9.025,"halted":0,"volume":44916142,"delay":0,"changeRate":0.004432132963988825,"floatShares":11522000000,"shares":11522000000,"eps":0.3984286010281364,"marketStatus":"未开盘","change":0.04,"latestTime":"10-13 16:08:28","open":9,"high":9.08,"low":8.81,"amount":402215998,"amplitude":0.029917,"askPrice":9.075,"askSize":510000,"bidPrice":9.065,"bidSize":64000,"shortable":3,"etf":0,"ttmEps":0.7627515731036377,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791941400000},"marketStatusCode":0,"adr":0,"listingDate":772128000000,"exchange":"SEHK","adjPreClose":9.025,"dividendRate":0.037305,"openAndCloseTimeList":[[1791855000000,1791864000000],[1791867600000,1791878400000]],"volumeRatio":0.715302,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"CSP.HK","impliedVol":0.4308,"impliedVolPercentile":0.0854},"requestUrl":"/m/hq/s/01093","defaultTab":"news","newsList":[{"id":"1163098223","title":"港股期权 | 半日成交超47万张！小米涨逾7%，26港元看涨期权交投最活跃；腾讯420港元认沽期权、阿里120港元看涨期权成交活跃","url":"https://stock-news.laohu8.com/highlight/detail?id=1163098223","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163098223?lang=zh_cn&edition=full","pubTime":"2026-10-09 12:44","pubTimestamp":1791521051,"startTime":"0","endTime":"0","summary":"今日半日港股股票期权成交量达472,535张。其中，10月9日到期、行权价26港元的认购期权成交居首，达3,443张；10月29日到期、行权价28港元及29港元的认购期权分别成交2,812张和2,408张。腾讯控股半日股价上涨1.90%，其中10月9日到期、行权价420港元及415港元的认沽期权交投活跃，分别成交3,794张和3,074张；2027年3月30日到期、行权价450港元的认购期权成交2,564张。","market":"hk","thumbnail":"https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03750","01024","09992","03690","00005","00100","01810","00700","01093","09988"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1156083504","title":"异动解读｜石药集团盘中下跌3.07%，创新药板块节后回调","url":"https://stock-news.laohu8.com/highlight/detail?id=1156083504","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156083504?lang=zh_cn&edition=full","pubTime":"2026-10-09 09:41","pubTimestamp":1791510061,"startTime":"0","endTime":"0","summary":"10月9日，石药集团盘中下跌3.07%，报9.0港元，成交额2.75亿港元。消息面上，创新药板块节后整体承压，艾力斯核心产品伏美替尼全球III期临床未达主要终点，引发市场对创新药管线兑现的担忧，港股制药股普遍走弱。尽管石药集团近期接连披露多项研发进展，包括SYS6002宫颈癌I期数据、8项ESMO年会临床进展及GLP-1糖尿病III期积极结果，但板块情绪拖累下，个股随行业调整。公司主要从事成药、原料药及功能食品业务，产品覆盖神经系统、抗肿瘤、抗感染、心血管等领域。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"石药集团下跌，创新药板块情绪承压","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674892318","title":"【券商聚焦】中泰国际：多家药企将公布重要数据 推荐创新药与CXO龙头","url":"https://stock-news.laohu8.com/highlight/detail?id=2674892318","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674892318?lang=zh_cn&edition=full","pubTime":"2026-10-09 08:38","pubTimestamp":1791506310,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中泰国际表示，多家创新药企业将于10月下旬ESMO公布重要临床数据。ESMO是欧洲最具盛名和影响力的肿瘤学会议，LBA是最高级别的研究成果展示，因此ESMO公布的LBA在医药行业广受关注。中国企业入选的LBA中，有四项入选最高级别的主席研讨会。该机构认为，以上情况表明中国创新药研发能力在海外广受认可，因此创新药板块值得继续关注。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993342","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125910500.SGD","BK1500","KURE","BK1521","LU1008478684.HKD","LU1688375341.USD","CXO","IBBQ","LU0348827113.USD","LU0327786744.USD","SG9999002463.SGD","LU0561508036.HKD","LU0572944931.SGD","02268","BK1191","KCE","IE00BZ08YR35.GBP","LU0307460666.USD","02359","00013","01801","LU0823426308.USD","LNGR","LU0348767384.USD","LU0149534421.HKD","IE00B5MMRT66.SGD","01093","09926","LU0320764599.SGD","159992","LU1831875114.USD","LU1960683339.HKD","LU0067412154.USD","LU0348783233.USD","WX","06160","LU0314109678.HKD","LU2097828714.EUR","06821","LU2399975544.HKD","LU0029874905.USD","LU0708995153.HKD","LU2488822045.USD","MEDX","IE0008369823.USD","02269","LU1242518931.SGD","LU2097828557.USD","01177","06978"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1152592461","title":"石药集团(01093)披露SYS 6002治疗晚期宫颈癌I期试验数据 确认客观缓解率最高35.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152592461","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152592461?lang=zh_cn&edition=full","pubTime":"2026-10-08 18:25","pubTimestamp":1791455144,"startTime":"0","endTime":"0","summary":"2026年10月8日，石药集团有限公司发布自愿公告称，其Nectin-4靶向抗体偶联药物SYS 6002在晚期宫颈癌患者中的I期临床试验最新数据已于2026年国际妇科肿瘤学会全球年会以快速口头报告形式公布。截至2026年5月8日，中位随访时间为16.1个月。间质性肺病和非感染性肺炎发生率为2.4%；未出现与治疗相关的死亡事件。目前，SYS 6002 2.4 mg/kg每2周给药方案用于免疫治疗经治晚期宫颈癌的III期临床试验正在进行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673750960","title":"石药集团(01093)：SYS6002单药用于治疗晚期宫颈癌的I期临床研究数据于IGCS2026上以快速口头报告形式公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2673750960","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673750960?lang=zh_cn&edition=full","pubTime":"2026-10-08 18:25","pubTimestamp":1791455112,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，本集团已于2026年国际妇科肿瘤学会全球年会上，以快速口头报告形式公布SYS6002单药用于治疗晚期宫颈癌的I期临床研究(该研究)数据。本次会议上，本集团公布了SYS6002单药治疗既往经治晚期宫颈癌的试验结果。目前，SYS6002 2.4 mg/kg每2周给药一次方案用于免疫治疗经治晚期宫颈癌的研究已进入 III 期临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504749.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"石药集团(01093)：SYS6002单药用于治疗晚期宫颈癌的I期临床研究数据于IGCS2026上以快速口头报告形式公布","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1152091754.HKD","LU1807302812.USD","01093","IE00BZ08YS42.EUR","LU1008478684.HKD","IE00B543WZ88.USD","LU1960683339.HKD","IE00BZ08YT58.USD","LU0880133367.SGD","LU2039709279.SGD","LU1226287875.USD","LU1328277881.USD","LU1813983027.USD","LU1951186391.HKD","BK1521","BK1515","LU1152091168.USD","KURE","SG9999004220.SGD","LU1226288253.USD","LU0067412154.USD","BK1191","LU0072913022.USD","IE0008368742.USD","LU0140636845.USD","IE00BZ08YR35.GBP","LU0326950275.SGD","HK0000165453.HKD","LU0501845795.SGD","LU0315179316.USD","LU0314109678.HKD","LU1226288170.HKD","LU1993786604.SGD","IE00B031HY20.USD","IE0008369823.USD","LU1226287529.USD","LU1226287792.SGD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169668209","title":"异动解读｜石药集团盘中下跌3.01%，ESMO数据兑现前创新药板块回调","url":"https://stock-news.laohu8.com/highlight/detail?id=1169668209","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169668209?lang=zh_cn&edition=full","pubTime":"2026-10-08 13:01","pubTimestamp":1791435697,"startTime":"0","endTime":"0","summary":"10月8日，石药集团盘中下跌3.01%，报9.52港元，成交额3.76亿港元。消息面上，公司日前宣布8项肿瘤临床试验进展将于10月底ESMO年会发布，但创新药板块整体走弱，港股制药股多数下跌，石药集团随板块回调。此前石药集团接连披露多项研发进展，市场关注ESMO临床数据兑现情况，但近期海外利率预期反复令创新药估值承压。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673041178","title":"港股开盘受压 恒指低开0.41% 汇丰控股（00005）跌2.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673041178","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673041178?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:27","pubTimestamp":1791422846,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股开盘受压，恒指低开0.41%，国企指数低开0.23%，恒生科技指数低开0.25%。汇丰控股跌2.40%，中国生物制药跌2.03%，华润电力跌1.97%，创科实业跌1.37%，万洲国际跌1.35%。剑桥科技低开2.01%，公司公告公布，拟配售1844.6万股。配售事项集资总额约为19.40亿港元，净额约19.30亿港元。初步转换价为每股H股128.82港元，较上交易日收市价114.30港元溢价约12.70%，可悉数转换为3598.33万股H股。乐动机器人低开1.52%，公司宣布，收购SABO-Maschinenfabrik GmbH全部股权，交易金额不超过600万欧元。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/YWY0NWM4YTUxZGFlZmZjNmE5MDYxNjI4NjU1Mjc3NzM1Mzg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YWY0NWM4YTUxZGFlZmZjNmE5MDYxNjI4NjU1Mjc3NzM1Mzg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993270","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1808992512.USD","603083","03115","BK1183","IE0008368742.USD","IE00B29SXG58.USD","IE00BYTNYN87.SGD","BK1568","LU0348767384.USD","LU1282651048.USD","LU1642822792.SGD","SG9999001226.SGD","LU0039217434.USD","HK0000286598.CNH","09067","LU1366334578.USD","LU0231483743.USD","LU1251922891.USD","LU0488056044.USD","LU0516422366.SGD","SG9999004220.SGD","03033","00178","LU0370786039.SGD","BK1179","LU0029874061.USD","LU0348825331.USD","IE0031814852.USD","BK1116","BK1530","LU0051755006.USD","BK1543","LU0228659784.USD","LU0871576103.HKD","LU1719994722.HKD","BK1224","LU0594300419.USD","LU0828237510.HKD","LU0345776255.USD","LU0516422440.USD","LU0516423174.USD","IE0008369823.USD","LU0106259558.USD","BK1615","LU0588545490.SGD","03143","LU1960683339.HKD","LU1282651121.HKD","09618","LU0541502299.USD","09115","LU0543330566.HKD","IE00B3M56506.USD","SG9999002562.SGD","BK1502","LU0164865239.USD","BK1589","07300","BK1191","LU2187417386.USD","SG9999001069.SGD","IE00BZ08YR35.GBP","00836","02800","LU1152091754.HKD","02833","03032","LU1282649067.USD","LU1328277881.USD","SG9999011746.SGD","IE0009570106.USD","BK1555","LU1226287875.USD","02228","LU0541501648.USD","LU1226288170.HKD","LU1226287529.USD","01177","LU0791590937.USD","LU0634319403.HKD","LU0320764599.SGD","LU2045819591.USD","513600","IE00B5MMRT66.SGD","LU1282648689.USD","LU0320764755.SGD","LU1807302812.USD","03088","BK1577","01236","LU1303224171.USD","KURE","LU1770036033.HKD","LU2449936058.SGD","LU0531971595.HKD","LU0274383008.USD","LU0417516738.SGD","LU1044875133.USD","LU1282649810.SGD","LU0431992006.USD","LU1813983027.USD","LU0128526141.USD","IE00BZ08YT58.USD","LU0865486749.SGD","LU1152091168.USD","SG9999000327.SGD","IE00B543WZ88.USD","LU1951186391.HKD","LU0229945570.USD","LU2008162690.USD","LU0348814723.USD","07500","LU0287142896.SGD","LU0345775950.USD","LU0877626530.USD","LU0588545904.SGD","BK1149","BK1588","LU0417516902.SGD","LU1119993845.HKD","LU0327786744.USD","00288","LU0499858438.USD","LU0516423091.SGD","LU0348805143.USD","LU0307460666.USD","07226","BK1570","HSTECH","09088","BK1240","601600","LU2125910500.SGD","BK1594","IE00BYQNZ168.SGD","07200","LU1023057109.AUD","LU0228367735.SGD","LU0672654166.SGD","SBHMY","BK1521","LU0469268626.HKD","LU0227179875.USD","06166","TTNDY","BK1249","BK1572","IE00B031HW06.USD","03419","LU0261947096.USD","LU1008478684.HKD","LU2351347302.SGD","BK1617","LU0359201885.HKD","82800","00669","LU2929501877.USD","WHGLY","BK1603","BK1601","HK0000165453.HKD","LU0348816934.USD","LU0543330483.HKD","SG9999002950.SGD","03750","BK1591","LU1102505929.USD","HSHD.SI","LU0880133367.SGD","LU0072913022.USD","LU1993786604.SGD","LU0164880469.USD","LU1366334651.USD","JD","LU0797268264.HKD","LU2257852520.SGD","LU0149721374.USD","LU0540923850.HKD","LU1720050803.USD","LU0499858602.USD","LU1166156734.SGD","LU0048597586.USD","LU1224444064.USD","LU0588546209.SGD","LU1794554557.SGD","LU0149534421.HKD","LU0251144936.SGD","LU0384037296.USD","LU0588545730.USD","LU0868486357.SGD","BK1610","03037","MCHmain","IE0032431581.USD","LU0791591158.USD","IE00B0169N27.USD","300750","BK1513","HSBC","LU1481107354.HKD","LU0516422952.EUR","BK1237","IE00BGV7N243.SGD","LU0359201612.USD","LU1226288253.USD","LU0572944931.SGD","LU1770034418.SGD","03423","LU0259732245.USD","SG9999001051.SGD","LU0067412154.USD","LU0048388663.USD","LU0173614495.USD","SG9999001689.USD","BK1142","LU1105468828.SGD","LGFRY","00960","02837","LU0456846285.SGD","IE0034224299.USD","IE00B12V2V27.USD","LU0315178854.USD","89618","LU1102505762.USD","LU2226246903.HKD","BK1175","BK1575","LU0052750758.USD","SG9999002828.SGD","BK1602","03417","BK1125","LU0128522157.USD","BK1619","LU0348735423.USD","LU1044876610.USD","LU0029875118.USD","LU2039709279.SGD","LU0211977185.USD","LU0650527681.SGD","LU0607220059.USD","LU0293314216.USD","BK1231","BK1525","LU2177674079.SGD","LU0501845795.SGD","SGXZ90724238.SGD","IE00BZ08YS42.EUR","LU0359202008.SGD","LU0315179316.USD","LU0314109678.HKD","02600","BK1592","LU0918141705.HKD","LU1226287792.SGD","83115","01093","HSBA.UK","HSI","IE00B031J352.USD","BK1515","LU0163747925.USD","LU1044874839.SGD","LU0348766576.USD","07552","BK1141","LU0708995583.HKD","IE00B031HY20.USD","LU0205439572.USD","03067","LU0326950275.SGD","IE0008368411.USD","LU0456827905.SGD","LU0702159699.USD","HHImain","LU0084288322.USD","LU0456842615.SGD","LU0918141887.USD","LU2242644610.SGD","LU0048580855.USD","00005","CRPJY","LU0140636845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673728701","title":"石药集团(01093)：8项最新临床试验进展将于2026年欧洲肿瘤内科学会(ESMO)年会上发布","url":"https://stock-news.laohu8.com/highlight/detail?id=2673728701","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673728701?lang=zh_cn&edition=full","pubTime":"2026-10-05 18:58","pubTimestamp":1791197912,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团(01093)发布公告，集团将于2026年10月23日至10月27日在西班牙马德里召开的欧洲肿瘤内科学会(ESMO)年会上展示8项最新临床试验进展，其中2项入选最新突破性摘要(Late-breaking Abstract, LBA)。本次入选的8项临床进展将分别以1项优选口头报告、3项快速口头报告、3项壁报及1项电子壁报的形式展示，覆盖乳腺癌、肺癌、胃癌、肝癌、结肠癌、胰腺癌、血管周围上皮样细胞瘤等瘤种，充分体现了集团在肿瘤治疗领域的研发实力与临床研究能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1503717.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BZ08YR35.GBP","LU1226287529.USD","BK1521","KURE","LU1226288253.USD","IE00B543WZ88.USD","BK1191","SG9999004220.SGD","BK1515","LU0315179316.USD","01093","LU0880133367.SGD","LU1226288170.HKD","LU1807302812.USD","LU1226287875.USD","LU1960683339.HKD","LU1226287792.SGD","LU0326950275.SGD","IE0008368742.USD","IE00BZ08YS42.EUR","LU2039709279.SGD","PSYK","IE00B5MMRT66.SGD","LU0140636845.USD","LU1152091754.HKD","IBBQ","LU0067412154.USD","LU0072913022.USD","IBBJ","MDTX","IE00B031HY20.USD","IE00BZ08YT58.USD","LU1152091168.USD","LU1951186391.HKD","LU0501845795.SGD","LU0314109678.HKD","LU1813983027.USD","LU1008478684.HKD","LU1328277881.USD","LU1993786604.SGD","BMED","IE0008369823.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138420406","title":"石药集团（01093）8项肿瘤创新成果将亮相2026年ESMO年会 两项入选“突破性摘要”","url":"https://stock-news.laohu8.com/highlight/detail?id=1138420406","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138420406?lang=zh_cn&edition=full","pubTime":"2026-10-05 18:55","pubTimestamp":1791197739,"startTime":"0","endTime":"0","summary":"石药集团10月5日发布自愿公告称，公司及其附属公司共8项最新肿瘤领域临床试验进展将于2026年10月23日至27日在西班牙马德里举行的欧洲肿瘤内科学会年会上集中展示，其中2项被大会选为“最新突破性摘要”。该适应症已于2026年5月获NMPA批准上市。HB1901于2025年2月获NMPA授予BTD。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673792787","title":"【券商聚焦】国金证券：行业有望迎业绩与估值戴维斯双击，创新药板块底部配置价值凸显","url":"https://stock-news.laohu8.com/highlight/detail?id=2673792787","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673792787?lang=zh_cn&edition=full","pubTime":"2026-10-05 08:50","pubTimestamp":1791161445,"startTime":"0","endTime":"0","summary":"随着后续管线商业化兑现、全球创新价值链话语权提升，行业有望迎来业绩与估值的戴维斯双击，创新药板块底部配置价值凸显。中国研究占全体大会核心LBA总量的1/3，这标志着中国肿瘤创新研发已深度融入全球研发体系，成为驱动全球肿瘤诊疗升级的重要力量，持续利好国内创新药企国际化发展与临床价值兑现。2026 ESMO已公布LBA标题，29项LBA的试验药物由中国药企原研或参与开发，涉及约20家企业，其中5项进入主席研讨会。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992996","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BPRC5H50.USD","01093","06160","HK0000165453.HKD","LU0244354667.USD","LU1794554557.SGD","LU2242644610.SGD","600109","MEDX","LU1226287875.USD","01877","01177","02269","06978","LU2399975544.HKD","LU1242518931.SGD","IE0008368742.USD","LU1807302812.USD","09688","LU0823426308.USD","BK1515","KURE","LNGR","BK1610","09926","BK1576","LU0315179316.USD","LU1226288253.USD","LU1328277881.USD","LU0856984785.SGD","KCE","LU0455707207.USD","LU0516422952.EUR","LU0314109678.HKD","LU0211977185.USD","LU0823426480.USD","BK0201","09995","02616","LU0052750758.USD","BK1583","06185","IBBQ","LU0359202008.SGD","LU0540923850.HKD","02142","BK1161","159992","01801","LU0043850808.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133020125","title":"石药集团2026年9月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1133020125","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133020125?lang=zh_cn&edition=full","pubTime":"2026-10-02 18:42","pubTimestamp":1790937743,"startTime":"0","endTime":"0","summary":"石药集团于2026年10月2日发布的月度报告显示，截至2026年9月30日，公司已发行股份总数维持在11,522,451,732股，与上月底保持一致，未发生增发、回购或注销等变动，库藏股数量也保持为0股。在指标方面，石药集团另披露，2015年及2026年购股权计划下的股份期权数量未发生变化，其中2026年5月28日生效的购股权计划在本月底的期权结存数为1,152,245,173份。石药集团表示，将持续严格遵循香港联交所相关上市规则和法律法规的要求，确保后续信息披露的准确与及时。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199231751","title":"异动解读｜石药集团盘中下跌3.13%，报9.72港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1199231751","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199231751?lang=zh_cn&edition=full","pubTime":"2026-10-02 09:46","pubTimestamp":1790905619,"startTime":"0","endTime":"0","summary":"10月2日，石药集团盘中下跌3.13%，报9.72港元/股，成交额6682.96万港元。石药集团所在的制药行业整体走弱，个股中，翰森制药跌4.31%，恒瑞医药跌4.26%，中国生物制药跌3.77%，凯莱英跌5.28%，先声药业跌4.73%。石药集团有限公司是一家主要从事药品的生产及销售的公司，产品主要涵盖神经系统、抗肿瘤、抗感染、心血管、呼吸系统、消化代谢以及其他治疗领域。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671920128","title":"石药集团(01093)：依达格鲁肽α注射液联合二甲双胍治疗中国成人2型糖尿病患者的III期临床研究结果于2026年第62届欧洲糖尿病研究协会年会(EASD 2026)上以简短口头讨论形式公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2671920128","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671920128?lang=zh_cn&edition=full","pubTime":"2026-09-30 20:11","pubTimestamp":1790770280,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，本集团已于2026年第62届欧洲糖尿病研究协会年会上，以简短口头讨论形式公布本集团研发的胰高血糖素样肽-1受体激动剂依达格鲁肽α注射液联合二甲双胍治疗中国成人2型糖尿病患者III期临床研究(该研究)的阳性结果。该研究结果表明，TG103注射液在该人群中展现出良好的疗效和安全性。TG103注射液各剂量组的低血糖发生率以及因不良事件导致的停药率均相对较低，且均未报告严重低血糖事件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502891.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"石药集团(01093)：依达格鲁肽α注射液联合二甲双胍治疗中国成人2型糖尿病患者的III期临床研究结果于2026年第62届欧洲糖尿病研究协会年会(EASD 2026)上以简短口头讨论形式公布","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0008368742.USD","LU1960683339.HKD","BK1191","LU1807302812.USD","LU1993786604.SGD","LU0880133367.SGD","LU1008478684.HKD","SG9999004220.SGD","LU1152091168.USD","LU0140636845.USD","LU1328277881.USD","IE00BZ08YR35.GBP","LU0315179316.USD","LU0072913022.USD","LU1226287529.USD","IE00B5MMRT66.SGD","LU1813983027.USD","BK1521","01093","HK0000165453.HKD","LU0326950275.SGD","LU1226287792.SGD","IE00B031HY20.USD","LU0501845795.SGD","LU1951186391.HKD","LU1226287875.USD","LU2039709279.SGD","LU1226288253.USD","IE00BZ08YS42.EUR","LU1152091754.HKD","LU1226288170.HKD","LU0067412154.USD","KURE","LU0314109678.HKD","IE00B543WZ88.USD","IE00BZ08YT58.USD","BK1515","IE0008369823.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671278515","title":"ETF异动 | AI制药赛道热度高涨 华夏恒生生科(03069)盘中涨超4% 华夏创新药(03525)午后涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671278515","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671278515?lang=zh_cn&edition=full","pubTime":"2026-09-30 13:44","pubTimestamp":1790747084,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，AI制药ETF延续近期涨势，截至发稿，华夏恒生生科涨3.58%，报16.8港元；华夏创新药涨2.95%，报10.48港元。消息面上，AI制药赛道热度高涨，AI4S正从“算力与模型”加速走向生物医药产业兑现。由OpenAI参投的生物科技初创公司Red Queen Bio计划于明年正式启动抗体药物的人体试验。同日，金斯瑞与礼来AI药物发现平台达成协作，公开资料显示，华夏恒生生科聚焦港股生物科技产业链，较大比例布局生命科学工具及服务企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502543.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01276","01093","LU0314109678.HKD","01548","BK4550","BK1610","LU1807302812.USD","KURE","BK4585","03069","SG9999004220.SGD","IE00B5MMRT66.SGD","QTOC","LU0072913022.USD","LU1152091168.USD","LU1226287529.USD","LU0067412154.USD","01477","IE0008368742.USD","LU0326950275.SGD","03525","LU0359202008.SGD","LU0501845795.SGD","BK1576","BK1521","LU1152091754.HKD","LU1993786604.SGD","VTHR","HK0000320223.HKD","IE0008369823.USD","HK0000306685.HKD","IE00B543WZ88.USD","LU1226287875.USD","LU1813983027.USD","LU2039709279.SGD","IE00BZ08YR35.GBP","FDN","IE00BZ08YS42.EUR","AIPO","CHAT","IE00BZ08YT58.USD","LU1951186391.HKD","LU1960683339.HKD","ARTY","AGIX","IE00B031HY20.USD","HK0000165453.HKD","BK1191","LU0359201885.HKD","LU1226287792.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671934224","title":"港股三大指数拉升转涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2671934224","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671934224?lang=zh_cn&edition=full","pubTime":"2026-09-30 10:57","pubTimestamp":1790737054,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE0008368742.USD","BK1583","IE00B5MMRT66.SGD","LU0359201612.USD","LU1023057109.AUD","LU2543165471.USD","LU0314109678.HKD","LU1807302812.USD","KURE","LU0315179316.USD","LU0326950275.SGD","LU0359202008.SGD","LU1226287875.USD","BK1574","HK0000165453.HKD","IE00B031HY20.USD","01276","BK1515","LU1960683339.HKD","BK1521","LU1226287529.USD","LU1328277881.USD","LU0067412154.USD","LU1226288253.USD","BK1191","LU1813983027.USD","LU0880133367.SGD","LU1993786604.SGD","LU2039709279.SGD","LU1951186391.HKD","LU0140636845.USD","IE00BZ08YT58.USD","01952","IE00BZ08YR35.GBP","SG9999004220.SGD","06978","LU1152091754.HKD","LU0359201885.HKD","LU1152091168.USD","LU0072913022.USD","IE00BZ08YS42.EUR","LU0501845795.SGD","LU1226288170.HKD","BK1161","IE0008369823.USD","LU1226287792.SGD","LU1008478684.HKD","IE00B543WZ88.USD","01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671222418","title":"创新药概念普涨 金斯瑞生物科技（01548）涨超10% 机构看好创新药及其产业链","url":"https://stock-news.laohu8.com/highlight/detail?id=2671222418","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671222418?lang=zh_cn&edition=full","pubTime":"2026-09-30 10:35","pubTimestamp":1790735739,"startTime":"0","endTime":"0","summary":"金吾财讯  | 创新药概念普涨，截至发稿，金斯瑞生物科技 涨10.10%，石药集团涨6.07%，云顶新耀涨5.79%，恒瑞医药涨5.18%，药明合联涨4.48%，晶泰控股涨4.06%，乐普生物涨3.52%，药明生物涨3.46%。消息面上，开源证券表示，整体上，持续看好创新药及其产业链及AI、脑机接口、生物制造等国家战略新兴产业。后续可重点跟踪ESMO临床数据、三季度订单及业绩验证和政策细则落地，积极把握优质创新药、CXO及生命科学上游调整后的配置机会。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/ZDlhMzNiODA0MWQ5OWM0NDQ5YzUxMTZmZWRlMTczNjQ3MzM4NzkwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/ZDlhMzNiODA0MWQ5OWM0NDQ5YzUxMTZmZWRlMTczNjQ3MzM4NzkwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992823","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348827113.USD","IBBQ","IE00B0JY6N72.USD","01276","LU0307460666.USD","BK1610","BK1521","LU0516422366.SGD","LU1188198961.HKD","LU1226288170.HKD","01548","01093","IE00BZ08YR35.GBP","BK1574","02269","LNGR","LU1813983027.USD","BK1515","KURE","BK1589","IE00BZ08YT58.USD","02228","LU0029874905.USD","BK1141","BK1161","SG9999004220.SGD","LU0072913022.USD","HK0000306701.USD","LU0540923850.HKD","LU0140636845.USD","01952","LU1688375341.USD","LU0880133367.SGD","LU0128522744.USD","LU1328277881.USD","LU1807302812.USD","LU0359201885.HKD","02157","LU1880383366.USD","159992","06978","LU0708995153.HKD","LU0823426480.USD","LU1242518931.SGD","MEDX","LU1242518857.USD","LU0181495838.USD","02268","LU1008478684.HKD","LU0039217434.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671221719","title":"港股异动 | 石药集团(01093)涨近6% 接连披露多项研发进展 涉及mRNA肿瘤疫苗、重组蛋白疫苗等方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2671221719","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671221719?lang=zh_cn&edition=full","pubTime":"2026-09-30 10:24","pubTimestamp":1790735081,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，石药集团涨近6%，截至发稿，涨5.86%，报10.03港元，成交额4.02亿港元。消息面上，9月28日至29日，石药集团连续披露多项研发进展，涉及mRNA肿瘤疫苗、重组蛋白疫苗及肥胖症治疗等方向。此前9月28日晚，石药集团公告，其开发的SYS 6077注射液已获中国国家药品监督管理局批准签发药物临床试验批准通知书，可在中国开展临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502482.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1226288170.HKD","LU1152091754.HKD","IE00BZ08YT58.USD","LU1008478684.HKD","LU1328277881.USD","KCAI","IE00BZ08YR35.GBP","IE0008369823.USD","LU0314109678.HKD","LU1226287875.USD","IE00B543WZ88.USD","BK1191","LU1152091168.USD","LU0072913022.USD","LU0880133367.SGD","KURE","LU1951186391.HKD","LU0140636845.USD","159646","LU0326950275.SGD","SG9999004220.SGD","VXUS","BK1515","LU0501845795.SGD","BK4588","BK4585","LU1813983027.USD","LU1226288253.USD","LU1993786604.SGD","LU1960683339.HKD","01093","IE0008368742.USD","BK1521","IE00B5MMRT66.SGD","IE00B031HY20.USD","LU1807302812.USD","LU2039709279.SGD","LU1226287529.USD","LU0067412154.USD","HK0000165453.HKD","LU0315179316.USD","LU1226287792.SGD","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119815064","title":"异动解读｜石药集团盘中上涨3.48%，带状疱疹疫苗获美国FDA临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1119815064","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119815064?lang=zh_cn&edition=full","pubTime":"2026-09-30 09:45","pubTimestamp":1790732718,"startTime":"0","endTime":"0","summary":"9月30日，石药集团盘中上涨3.48%，报9.8港元，成交额1.09亿港元。消息面上，公司9月29日连发两项研发进展公告：其自主研发的重组带状疱疹疫苗SYS6052获美国FDA批准在美国开展临床试验，该疫苗此前已于7月获中国NMPA批准开展国内临床，此次为公司在重组蛋白疫苗领域首获美国临床许可，标志着预防性疫苗全球化布局正式启动；同日，公司减重药物JMT206注射液在中国首家研究中心启动Ib期临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"石药集团拉升，带状疱疹疫苗获美国临床批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193918647","title":"石药集团(01093)重组带状疱疹疫苗获美国FDA临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1193918647","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193918647?lang=zh_cn&edition=full","pubTime":"2026-09-29 18:05","pubTimestamp":1790676344,"startTime":"0","endTime":"0","summary":"石药集团有限公司(01093)9月29日公告称，其自主研发的1类新药重组带状疱疹疫苗(SYS 6052)已获得美国食品药品监督管理局(FDA)批准，可在美国开展临床研究。\n该产品由水痘-带状疱疹病毒gE蛋白抗原与公司自主开发的新型纳米佐剂系统组成，临床适应症为50岁及以上成人，用于预防带状疱疹及其并发症。\n公告显示，SYS 6052此前已于2026年7月获得中国国家药品监督管理局(NMPA)批准在国内开展临床试验。本次获批为石药集团在重组蛋白疫苗领域取得的首个美国临床试验许可。\n公司表示，此次获批为包括重组带状疱疹疫苗在内的预防性疫苗产品的全球开发奠定了基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670236373","title":"石药集团(01093.HK)：SYS 6077注射液在中国获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2670236373","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670236373?lang=zh_cn&edition=full","pubTime":"2026-09-28 18:11","pubTimestamp":1790590293,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1951186391.HKD","LU0501845795.SGD","IE00B5MMRT66.SGD","LU1152091754.HKD","LU0072913022.USD","BK1521","IE00BZ08YS42.EUR","LU2039709279.SGD","LU0067412154.USD","01093","IE00BZ08YR35.GBP","LU0140636845.USD","LU1993786604.SGD","IE00BZ08YT58.USD","LU0326950275.SGD","BK1191","LU1226288170.HKD","LU1008478684.HKD","LU1813983027.USD","LU1328277881.USD","LU1226287875.USD","IE0008368742.USD","LU1226287792.SGD","LU1152091168.USD","LU1226287529.USD","BK1515","KURE","LU0880133367.SGD","LU1807302812.USD","LU0315179316.USD","IE00B031HY20.USD","LU1960683339.HKD","HK0000165453.HKD","LU0314109678.HKD","IE0008369823.USD","LU1226288253.USD","SG9999004220.SGD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cspc.com.hk","stockEarnings":[{"period":"1week","weight":-0.0935},{"period":"1month","weight":0.0408},{"period":"3month","weight":0.0753},{"period":"6month","weight":-0.0087},{"period":"1year","weight":-0.0053},{"period":"ytd","weight":0.0995}],"compareEarnings":[{"period":"1week","weight":0.0027},{"period":"1month","weight":-0.0186},{"period":"3month","weight":-0.0136},{"period":"6month","weight":-0.0776},{"period":"1year","weight":-0.0596},{"period":"ytd","weight":-0.0501}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"石药集团有限公司是一家主要从事药品的生产及销售的公司。该公司主要从事成药业务、原料产品业务、功能食品及其他业务。该公司的产品主要涵盖神经系统、抗肿瘤、抗感染、心血管、呼吸系统、消化代谢以及其他治疗领域。该公司的产品销往国内外市场。","yearOnYearQuotes":[{"month":1,"riseRate":0.53125,"avgChangeRate":0.009625},{"month":2,"riseRate":0.75,"avgChangeRate":0.094313},{"month":3,"riseRate":0.46875,"avgChangeRate":0.017543},{"month":4,"riseRate":0.59375,"avgChangeRate":0.057684},{"month":5,"riseRate":0.59375,"avgChangeRate":0.042479},{"month":6,"riseRate":0.3125,"avgChangeRate":0.001853},{"month":7,"riseRate":0.393939,"avgChangeRate":0.015989},{"month":8,"riseRate":0.454545,"avgChangeRate":0.011919},{"month":9,"riseRate":0.515152,"avgChangeRate":0.003046},{"month":10,"riseRate":0.545455,"avgChangeRate":0.006683},{"month":11,"riseRate":0.46875,"avgChangeRate":0.006831},{"month":12,"riseRate":0.5,"avgChangeRate":-0.013329}],"exchange":"SEHK","name":"石药集团","nameEN":"CSPC PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"石药集团,01093,石药集团股票,石药集团股票老虎,石药集团股票老虎国际,石药集团行情,石药集团股票行情,石药集团股价,石药集团股市,石药集团股票价格,石药集团股票交易,石药集团股票购买,石药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}